What is NDC 31722-415?

31722-415 is the product NDC for Temozolomide, Temozolomide 180 mg/1 capsule, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Temozolomide?

63 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Temozolomide NDC 31722-415 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-415Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0415Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-415-14	31722041514	14 CAPSULE in 1 BOTTLE (31722-415-14)Marketed from Aug 23, 2024
31722-415-31	31722041531	5 CAPSULE in 1 BOTTLE (31722-415-31)Marketed from Aug 23, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Temozolomide
Generic name (nonproprietary): temozolomide
Active ingredients: Temozolomide — 180 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210030
Marketing start: Aug 23, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Alkylating Activity (Mechanism)
Identifiers: Product ID 31722-415_24d38de8-4acf-bdac-e063-6394a90ad431SPL ID 24d38de8-4acf-bdac-e063-6394a90ad431SPL set ID 78c12889-c837-40c1-8f85-4d048008ad29RxCUI 313209, 313210, 313211, 317160, 700883, 700885UNII YF1K15M17YUPC 0331722415316, 0331722414319, 0331722413312, 0331722411318, 0331722412315, 0331722416313
Pharmacologic class: Alkylating Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722041514 followed by a unit qualifier and the quantity

Package 31722-0415-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 19, 2024.

Indications (excerpt from the label)

Temozolomide capsule is an alkylating drug indicated for the treatment of adults with: • Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. ( 1.1 ) • Anaplastic astrocytoma. ( 1.2 ) o Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma. ( 1.2 ) o Treatment of adults with refractory anaplastic astrocytoma. ( 1.2 ) 1.1 Newly Diagnosed Glioblastoma Temozolomide capsules are indicated for the treatment of adults with newly diagnosed glioblastoma, concomitantly with radiotherapy and then as maintenance treatment. 1.2 Anaplastic Astrocytoma Temozolomidecapsules are indicated for the: •adjuvant treatment of adults with newly diagnose…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-415

What is NDC 31722-415?: 31722-415 is the product NDC for Temozolomide, Temozolomide 180 mg/1 capsule, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Temozolomide.
What is the active ingredient?: Temozolomide.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Temozolomide?: 63 other product NDCs are listed under this name. See all Temozolomide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Temozolomide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Temozolomide	Temozolomide 100 mg/1	CapsuleOral	OPKO Pharmaceuticals, LLC	70301-2005	70301-2005-0170301-2005-02
Temozolomide	Temozolomide 140 mg/1	CapsuleOral	OPKO Pharmaceuticals, LLC	70301-2007	70301-2007-0170301-2007-02
Temozolomide	Temozolomide 180 mg/1	CapsuleOral	OPKO Pharmaceuticals, LLC	70301-2009	70301-2009-0170301-2009-02
Temozolomide	Temozolomide 250 mg/1	CapsuleOral	OPKO Pharmaceuticals, LLC	70301-2011	70301-2011-01
Temozolomide	Temozolomide 5 mg/1	CapsuleOral	CivicaScript LLC	82249-404	82249-0404-0582249-0404-14
Temozolomide	Temozolomide 20 mg/1	CapsuleOral	CivicaScript LLC	82249-406	82249-0406-0582249-0406-14
Temozolomide	Temozolomide 100 mg/1	CapsuleOral	CivicaScript LLC	82249-408	82249-0408-0582249-0408-14
Temozolomide	Temozolomide 140 mg/1	CapsuleOral	CivicaScript LLC	82249-410	82249-0410-0582249-0410-14
Temozolomide	Temozolomide 180 mg/1	CapsuleOral	CivicaScript LLC	82249-412	82249-0412-0582249-0412-14
Temozolomide	Temozolomide 250 mg/1	CapsuleOral	CivicaScript LLC	82249-414	82249-0414-05

All 64 Temozolomide NDCs

Other NDCs under ANDA 210030

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210030
Product	Strength	Form · route	Labeler	Product NDC
Temozolomide	Temozolomide 5 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-411
Temozolomide	Temozolomide 20 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-412
Temozolomide	Temozolomide 100 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-413
Temozolomide	Temozolomide 140 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-414
Temozolomide	Temozolomide 250 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-416